Banerji M A, Lebovitz H E
Department of Medicine, State University of New York, Brooklyn, New York 11203.
Medicine (Baltimore). 1990 May;69(3):176-85. doi: 10.1097/00005792-199005000-00005.
Normoglycemic remission has been observed in black non-insulin-dependent diabetic individuals. Thirty-three patients presented with severe hyperglycemia (mean glucose 682 mg/dl) and were hospitalized for initial treatment. Following intensive outpatient therapy including insulin or sulfonylurea for 0.25 to 96 weeks, they became normoglycemic without pharmacologic treatment. This state was characterized by normal glycosylated hemoglobin levels in 29 of 30 patients and fasting plasma glucose levels of less than or equal to 115 mg/dl in 25 of 33 patients. During clinical remission these individuals were characterized as being lean to moderately obese (body mass index less than 30.5 kg/m), relatively young (45 years of age), and largely male (male:female ratio was 2:1). Thirty percent of the patients underwent normoglycemic remission after 3 months of treatment, 64% within 6 months, and 85% within 12 months. Normoglycemic remission was not related to weight loss or amelioration of stress and lasted from several months to as long 97 months. The results of the oral glucose tolerance test during remission showed that 9 had normal, 7 had impaired, and 17 had diabetic glucose tolerance. Thirteen of the 33 patients relapsed and developed hyperglycemia after a mean of 24.9 months. Relapse was not associated with weight gain or acute stress. Islet cell antibodies were uniformly absent, implying that these individuals did not have an autoimmune form of diabetes. It is not known if remission in non-insulin-dependent diabetes is unique to the black population. Neither the prevalence nor the mechanism of the development of remission is known at this time.
在非胰岛素依赖型糖尿病黑人个体中观察到了血糖正常缓解情况。33例患者出现严重高血糖(平均血糖682mg/dl)并住院接受初始治疗。在接受包括胰岛素或磺脲类药物在内的强化门诊治疗0.25至96周后,他们在未接受药物治疗的情况下血糖恢复正常。这种状态的特征是,30例患者中有29例糖化血红蛋白水平正常,33例患者中有25例空腹血糖水平小于或等于115mg/dl。在临床缓解期间,这些个体的特征是体型偏瘦至中度肥胖(体重指数小于30.5kg/m)、相对年轻(45岁)且以男性为主(男女比例为2:1)。30%的患者在治疗3个月后实现血糖正常缓解,6个月内为64%,12个月内为85%。血糖正常缓解与体重减轻或应激改善无关,持续时间从数月至长达97个月不等。缓解期间口服葡萄糖耐量试验结果显示,9例葡萄糖耐量正常,7例受损,17例糖尿病葡萄糖耐量。33例患者中有13例在平均24.9个月后复发并出现高血糖。复发与体重增加或急性应激无关。胰岛细胞抗体均未检出,这意味着这些个体不存在自身免疫性糖尿病形式。尚不清楚非胰岛素依赖型糖尿病的缓解是否仅在黑人人群中出现。目前既不清楚缓解的患病率,也不清楚其发生机制。